Highlights from SABCS 2022- Recorded Webcast

This accredited continuing education activity “Highlights from SABCS 2022”, was recorded from the live course held on 1/21/2023. 

If you participated in the live course titled - Highlights from SABCS 2022 on 1/21/2023 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This was recorded from the live course on 1/21/2023.  However, you may enroll in this activity to review the contents. 

Management of breast cancer is rapidly evolving. A number of potentially practice-changing abstracts are expected to be presented during the 2022 San Antonio Breast Cancer Symposium (SABCS 2022) in December, 2022. At the in-person oncology conference held in Seattle,  Highlights from SABCS 2022, expert faculty placed abstract findings from the SABCS 2022 annual meeting into clinical context and discussed how the results changed the current standard of care for breast cancer patients.

REGISTRATION FEES:

This activity is free for all.

Target Audience

  • Medical Oncologists
  • Radiation Oncologists
  • Surgeons
  • Residents/fellows
  • NPs/PAs
  • Pharmacists
  • Nurses

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Review potentially practice-changing abstracts presented at the 2022 San Antonio Breast Cancer Symposium and discuss their application in clinical settings. 
  • Discuss the study design and primary endpoints of recently reported and ongoing clinical trials that have influenced the changes in standards of care in breast cancer
  • Compare and contrast the safety and efficacy profiles of novel therapeutic strategies that impact breast cancer management.
  • Integrate emerging evidence into treatment paradigms for the treatment of patients with breast cancer
  • Individualize management of early-stage or advanced breast cancer patients based on emerging data from clinical trials and evolving expert guidelines.
Course summary
Available credit: 
  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
Course opens: 
02/07/2023
Course expires: 
01/20/2024
Cost:
$0.00

This educational activity features recorded videos from the live course titled - Highlights from SABCS 2022 held Jan 21, 2023.

The videos are placed in the following order. Feel free to view the content that is relevant to you.

Participants should claim continuing education credits to the extent of their participation.

Session 1:

30 minutes: HER2- Low: Pathology Review - Elizabeth U. Parker, MD

30 minutes: HER2-Low: A Separate Entity - Jennifer Specht, MD

25 minutes: Antibody Drug Conjugates: Future Directions and Opportunities - David B. Page, MD

20 minutes: Case discussion, Q&A. HER2-Low case - Nanette Robinson, MD

Session 2:

25 minutes: ER+ Breast Cancer: Past, Present, and Future - Hannah Linden, MD

30 minutes: HER2+ Updates and Leads for the Future – (Neo)/Adjuvant and Advanced Settings - William Gwin III., MD

30 minutes: Advances in Approaches to Triple Negative Breast Cancer - Christos Vaklavas, M.D.

25 minutes: Case discussion on POSITIVE Trial - Poorni Manohar, MD

Session 3:

30 minutes: Challenging the Historic Locoregional Therapy while Improving Quality of Life - Janice Kim, MD

30 minutes: State-of-the-Art Radiotherapy: Increasing Options through Hypofractionation and Reducing Toxicity - Astrid Morris, MD

20 minutes: Local Surgical Therapy - Best Breast Practice - Kristine Calhoun, MD

55 minutes: Case Discussions, Q&A - Ying Zhuo, MD, Wendy Wang MD, Ph.D., Natalie Uy, MD

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

 

Hannah Linden, MD: has a financial relationship (Research support/Grant) with GE; has a financial relationship (Research support/Grant) with Sanofi; has a financial relationship (Research support/Grant) with Veru; has a financial relationship (Research support/Grant) with Zeno; has a financial relationship (Research support/Grant) with Tolmar.

 

COURSE DIRECTOR(S)

Janice Kim, MD has no relevant financial relationships to disclose at this time.

Fengting Yan, MD has no relevant financial relationships to disclose at this time.


MODERATORS

Nancy Davidson, MD has no relevant financial relationships to disclose at this time.

Amber Post, MD, Ph.D. has no relevant financial relationships to disclose at this time.

Michaela Tsai, MD has no relevant financial relationships to disclose at this time.

Tanya Wahl, MD has no relevant financial relationships to disclose at this time.


PLANNERS

Angelena Crown, MD has no relevant financial relationships to disclose at this time.

Janice Kim, MD has no relevant financial relationships to disclose at this time.

Xiaowen (Wendy) Wang, MD, Ph.D. has no relevant financial relationships to disclose at this time.

Fengting Yan, MD has no relevant financial relationships to disclose at this time.


SPEAKERS

Kristine Calhoun, MD has no relevant financial relationships to disclose at this time.

Danielle File, MD has no relevant financial relationships to disclose at this time.

William Gwin III, MD has no relevant financial relationships to disclose at this time.

Hiba Khan, MD, MPH has no relevant financial relationships to disclose at this time.

Poorni Manohar, MD has no relevant financial relationships to disclose at this time.

Astrid Morris, MD has no relevant financial relationships to disclose at this time.

David B. Page, MD has a financial relationship (Grant Or Contract) with Merck; financial relationship (Independent contractor) with Novartis; financial relationship (Independent contractor) with Brooklyn Immunotherapeutics; financial relationship (Independent contractor) with Sanofi; financial relationship (Grant Or Contract) with WindMIL; financial relationship (Independent contractor) with Merck; financial relationship (Independent contractor) with NGM Bio; financial relationship (Independent contractor) with Clinical Care Options; financial relationship (Grant Or Contract) with Brooklyn Immunotherapeutics; financial relationship (Independent contractor) with Oncocyte; financial relationship (Independent contractor) with Lilly; financial relationship (Independent contractor) with Astrazeneca/D-S; financial relationship (Grant Or Contract) with BMS; financial relationship (Independent contractor) with Genentech; financial relationship (Independent contractor) with Sanford Burnham Presbys; financial relationship (Professional Services) with Biotheranostics.

Elizabeth Parker, MD has no relevant financial relationships to disclose at this time.

Nanette Robinson, MD has no relevant financial relationships to disclose at this time.

Jennifer Specht, MD has no relevant financial relationships to disclose at this time.

Natalie Uy, MD has no relevant financial relationships to disclose at this time.

Christos Vaklavas, MD, Associate Professor, has a financial relationship (Professional Services) with Novartis; a financial relationship (Professional Services) with AstraZeneca; a financial relationship (Financial Support) with H3 Biomedicine; a financial relationship (Professional Services) with Guidepoint; financial relationship (Professional Services) with Gilead; financial relationship (Financial Support) with SeaGen; financial relationship (Employment) with Flatiron; financial relationship (Professional Services) with Daiichi Sankyo; financial relationship (Financial Support) with Pfizer; financial relationship (Financial Support) with CytomX; financial relationship (Professional Services) with SeaGen; financial relationship (Professional Services) with AstraZeneca; financial relationship (Financial Support) with AstraZeneca.

Xiaowen (Wendy) Wang, MD, Ph.D. has no relevant financial relationships to disclose at this time.

Fengting Yan, MD has no relevant financial relationships to disclose at this time.

Ying Zhuo, MD has no relevant financial relationships to disclose at this time.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported by an independent medical education grant from the following companies:

  • Gilead Sciences
  • Exact Sciences.

Important Information about Claiming CME for this activity:

If you participated in the live course titled - Highlights from SABCS 2022 on 1/21/2023 and claimed CME credits/MOC points for that activity, you do not qualify for CME credits/MOC points for your participation in this enduring activity. This was recorded from the live course on 1/21/2023. 

 

Available Credit

  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.

Price

Cost:
$0.00
Please login or register to take this course.

REGISTRATION FEES:

This activity is free for all.